A carregar...

Deprivation of arginine by recombinant human arginase in prostate cancer cells

BACKGROUND: Recombinant human arginase (rhArg) has been developed for arginine deprivation therapy in cancer, and is currently under clinical investigation. During pre-clinical evaluation, rhArg has exhibited significant anti-proliferative activity in cancer cells deficient in the expression of orni...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hsueh, Eddy C, Knebel, Stephanie M, Lo, Wai-Hung, Leung, Yun-Chung, Cheng, Paul Ning-Man, Hsueh, Chung-Tsen
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3403903/
https://ncbi.nlm.nih.gov/pubmed/22546217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-5-17
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!